
Opinion|Videos|September 13, 2024
Similarities and Differences among Bispecifics: BCMA vs non-BCMA
Medical experts examine differences and similarities in the referral process and treatment protocols for non–BCMA-targeted vs BCMA-targeted bispecific therapies, including aspects like step-up dosing and premedication.
Advertisement
Episodes in this series

Video content above is prompted by the following:
Is the process different/similar for patients who might be receiving non–BCMA-targeted bispecific vs BCMA-targeted bispecific?
Review any differences/similarities between bispecifics (non-BCMA vs BCMA) for step-up dosing, premedication/prophylaxis, etc.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
A Look Back on the Top 10 Oncology Interviews in 2025
3
Zovegalisib Combo Confers Efficacy Benefit in PIK3CA-Mutated Breast Cancer
4
‘Relatively Low’ AEs Noted With Durvalumab/FLOT in Gastric/GEJ Cancer
5

